Bank of New York Mellon »

Skye Bioscience shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-06-30 $471k 59k 8.01

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Meta Platforms Inc-class A Cl A (META)
Ishares Core S&p 500 Etf Core (IVV)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Taiwan Semiconductor-sp Spon (TSM)

View all positions for Bank of New York Mellon

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
Henderson Group
Vanguard Group
CVI Holdings
Driehaus Capital Management
Point72 Asset Management
Baker Bros. Advisors
Perceptive Advisors
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Skye Bioscience